Self-reported pediatricians' management of the well-appearing young child with fever without a source: first survey in an European country in the anti-pneumococcal vaccine era.
BACKGROUND
Recent studies suggest a substantially reduced risk of invasive bacterial infection in children vaccinated with heptavalent pneumococcal conjugate vaccine (PCV). To investigate whether the introduction of PCV might affect clinical decision making, we conducted a cross-sectional survey aimed at Italian Pediatric physicians.


RESULTS
The study included 348 (46.5%) primary care pediatricians; 251 (36.4%) hospital pediatricians, and 139 (20.1%) pediatric residents. In an hypothetical scenario, a well-appearing 12-month-old child with fever without source would be sent home with no therapy by 60.7% (419/690) of physicians if the child was not vaccinated with PCV. The proportion increased to 74.2% (512/690) if the child had received PCV (P < 0.0001). Also, physicians would obtain blood tests less frequently in the vaccinated than in unvaccinated children (139/690 [20.1%] vs. 205/690 [29.7%]; P < 0.0001), and started empiric antibiotic therapy less frequently (3.0% vs. 7.5%; P < 0.0001). In the hypothetical event that white blood cell count was 17,500/microL, a significantly lower proportion of physicians would ask for erythrocyte sedimentation rate (P < 0.017), C reactive protein (P < 0.0001), blood culture (P = 0.022), and urine analysis or dipstick (P = 0.028), if the child had received PCV. Only one third of participants routinely recommended PCV.


CONCLUSIONS
Our data suggest that implementation of educational programs regarding the proper management of the febrile child is needed.
Chiappini
Elena
E
Department of Pediatrics, University of Florence, Florence, Italy. echiappini@unifi.it
Galli
Luisa
L
Bonsignori
Francesca
F
Venturini
Elisabetta
E
Principi
Nicola
N
de Martino
Maurizio
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005334:Fever / Q000188:drug therapy*; D006801:Humans; D010372:Pediatrics; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D010818:Practice Patterns, Physicians'; D000078329:Workforce
D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines
J Infect. 2008 Mar;56(3):179-84
18222005
Pediatr Clin North Am. 2006 Apr;53(2):167-94
16574521
Pediatr Emerg Care. 2006 Aug;22(8):566-9
16912624
Pediatr Infect Dis J. 1998 Apr;17(4):271-7; discussion 277-9
9576380
J Infect Dis. 2008 Apr 1;197(7):1016-27
18419539
Ann Emerg Med. 2000 Dec;36(6):602-14
11097701
J Am Board Fam Pract. 2003 Sep-Oct;16(5):363-71
14645326
Pediatr Ann. 1993 Aug;22(8):497-8, 501-4
8414705
Int J Qual Health Care. 1999 Jun;11(3):187-92
10435838
JAMA. 2007 Apr 25;297(16):1784-92
17456820
N Engl J Med. 2009 Jan 15;360(3):244-56
19144940
Arch Pediatr Adolesc Med. 2002 Jan;156(1):44-54
11772190
Vaccine. 2007 Aug 29;25(35):6437-46
17673339
Arch Pediatr Adolesc Med. 2004 Jul;158(7):695-701
15237070
Am Fam Physician. 2007 Jun 15;75(12):1805-11
17619522
J Infect Dis. 2007 Nov 1;196(9):1346-54
17922399
JAMA. 2007 Apr 25;297(16):1825-6
17456826
Acad Emerg Med. 1998 Jun;5(6):599-606
9660287
Ann Emerg Med. 2003 Oct;42(4):530-45
14520324
Curr Opin Pediatr. 2008 Feb;20(1):96-102
18197047
JAMA. 2007 Oct 17;298(15):1772-8
17940232
Clin Pediatr (Phila). 2004 Jan-Feb;43(1):75-82
14968896